Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatocyte surface receptors mediating Plasmodium falciparum sporozoite entry are a group of host proteins that the malaria parasite exploits to gain entry into the liver. This group primarily includes CD81, Scavenger receptor class B member 1 (SR-B1), Ephrin type-A receptor 2 (EphA2), and Heparan sulfate proteoglycans (HSPGs) (Silvie et al., 2003, Nature Medicine; Silvie et al., 2006, PLoS Biology). These receptors facilitate different stages of the invasion process, from initial low-affinity docking (HSPGs) to the formation of a committed parasitophorous vacuole (CD81 and SR-B1) (Rodrigues et al., 2008, Hepatology). Because these receptors are essential for the establishment of the liver stage of infection, they are considered high-value targets for prophylactic antimalarial strategies (Kaushansky et al., 2015, Science). However, many of these proteins have critical physiological functions, such as SR-B1's role in high-density lipoprotein (HDL) metabolism and CD81's involvement in B-cell signaling. Consequently, therapeutic development focusing on these receptors must ensure that the inhibition of parasite entry does not lead to significant host toxicity or metabolic disruption.
Inhibition of host-parasite protein-protein interactions to prevent sporozoite invasion of hepatocytes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatocyte surface receptors mediating Plasmodium falciparum sporozoite entry.